Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Microbicides news

Show

From To
Testing HIV Prevention Tools: Other Ways Up the Alley

We need to design prevention trials that ask, “Is this test product better than nothing?” rather than, “Is this test product better than the best available prevention combination we have?”

Published
15 March 2013
From
Poz
Mitchell Warren: Listening to Women's Voices on HIV Prevention

The VOICE trial results show that we still have a lot to learn about what women really want and need in HIV prevention. The women in the trial are telling us something that is true for every group at risk for HIV: to help more people avoid infection, we need to offer prevention tools they will actually want, demand and use.

Published
12 March 2013
From
Huffington Post
Bee Venom Destroys HIV And Spares Surrounding Cells

Nanoparticles containing bee venom toxin melittin can destroy human immunodeficiency virus (HIV) while at the same time leaving surrounding cells unharmed, scientists from Washington University School of Medicine reported in the March 2013 issue of Antiviral Therapy.

Published
10 March 2013
From
HIV / AIDS News From Medical News Today
CROI 2013: The VOICE Results—A Social Scientist’s Perspective

To social scientist Judith D. Auerbach, PhD, a consultant to the NIH Office of AIDS Research and San Francisco AIDS Foundation, the VOICE results raise a number of questions—but not the ones you might think.

Published
06 March 2013
From
BETA blog
After VOICE trial, question remains: What were women telling researchers?

The results were disappointing in every way: the products evaluated were not shown to be effective, the adherence to using the products was dismal – and cancelling the possibility of learning if the products conferred any protection, it was worst among the demographic at highest risk — the younger, unmarried women.

Published
05 March 2013
From
Science Speaks
Statements on the VOICE results

Comments on the disappointing vaginal microbicide and PrEP results from AVAC, the Gates Foundation, the NIH, and others.

Published
05 March 2013
From
AVAC
Monthly injectable drug offers 100% protection against HIV in monkeys – could be dosed every three months

An injectable, long-lasting integrase inhibitor drug, when given to rhesus macaques exposed to a monkey-adapted version of HIV, completely protected them against the virus. This drug, an injectable

Published
04 March 2013
By
Gus Cairns
VOICE trial's disappointing result poses big questions for PrEP

The failure of one of the largest trials yet conducted of HIV drug-based prevention methods poses questions for how to turn vaginal microbicides and oral pre-exposure prophylaxis

Published
04 March 2013
By
Gus Cairns
Rectal microbicide research takes giant leap forward with groundbreaking educational video

In advance of the first-ever phase II trial of a rectal microbicide, IRMA, the Population Council and the Microbicides Trials Network release "The Rectal Revolution Is Here: An Introduction to Rectal Microbicide Clinical Trials". The jointly produced video, the first of its kind, is designed to educate communities affected by HIV about rectal microbicide development and the importance of participating in clinical trials to help speed the search for new HIV prevention options.

Published
19 December 2012
From
IRMA - International Rectal Microbicide Advocates
Electrically spun fabric offers dual defense against pregnancy, HIV

A University of Washington team has developed a versatile platform to simultaneously offer contraception and prevent HIV. Electrically spun cloth with nanometer-sized fibers can dissolve to release drugs, providing a platform for cheap, discrete and reversible protection.

Published
10 December 2012
From
University of Washington press release

Filter by country